Review: taking Tramadol hydrochloride and Duspatal together


Summary

Drug interactions are reported among people who take Tramadol hydrochloride and Duspatal together. This review analyzes the effectiveness and drug interactions between Tramadol hydrochloride and Duspatal. It is created by eHealthMe based on reports of 127 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Tramadol hydrochloride and Duspatal >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Tramadol Hydrochloride

Tramadol hydrochloride has active ingredients of tramadol hydrochloride. It is often used in pain. (latest outcomes from Tramadol hydrochloride 7,336 users)

Duspatal

Duspatal has active ingredients of mebeverine hydrochloride. It is often used in crohn's disease. (latest outcomes from Duspatal 224 users)

On Aug, 24, 2016

127 people who take Tramadol Hydrochloride, Duspatal are studied.


Number of reports submitted per year:

Tramadol hydrochloride and Duspatal drug interactions.

Drug effectiveness over time:

Tramadol Hydrochloride:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Duspatal:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Tramadol Hydrochloride:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)
Duspatal:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Tramadol Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Duspatal:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • encephalopathy
  • gastroenteritis
  • hepatic neoplasm malignant
  • international normalised ratio increased
  • dysgeusia
  • vision blurred
  • visual acuity reduced
  • cholecystitis acute
  • diarrhoea
  • dizziness
1 - 6 months:
  • dysgeusia
1 - 2 years:
  • circulatory collapse
  • death
  • overdose
not specified:
  • dyspnoea
  • mouth ulceration
  • swollen tongue
  • anaemia
  • rectal haemorrhage
  • pancytopenia
  • abdominal pain
  • bone marrow toxicity
  • rheumatoid arthritis
  • neutropenic sepsis

Most common drug interactions by gender *:

female:
  • dyspnoea
  • mouth ulceration
  • swollen tongue
  • rheumatoid arthritis
  • abdominal pain
  • international normalised ratio increased
  • dysgeusia
  • change of bowel habit
  • myalgia
  • sleep disorder
male:
  • anaemia
  • rectal haemorrhage
  • bone marrow toxicity
  • pancytopenia
  • neutropenic sepsis
  • febrile neutropenia
  • haematuria
  • bladder cancer
  • encephalopathy
  • aggression

Most common drug interactions by age *:

20-29:
  • abdominal pain
  • haemoglobin decreased
  • haemorrhoidal haemorrhage
  • malaise
  • pancytopenia
  • platelet count decreased
  • rectal haemorrhage
  • weight decreased
30-39:
  • circulatory collapse
  • overdose
  • pancreatitis acute
  • abdominal pain
  • death
  • syncope
  • vomiting
  • abdominal distension
  • aggression
  • agoraphobia
40-49:
  • pain
  • dyspnoea
  • lower respiratory tract infection
  • mobility decreased
  • movement disorder
  • pharyngitis
  • prostate infection
  • aggression
  • agoraphobia
  • blindness
50-59:
  • rheumatoid arthritis
  • abdominal pain
  • haematuria
  • change of bowel habit
  • myalgia
  • sleep disorder
  • bladder cancer
  • encephalopathy
  • anal abscess
  • hepatic neoplasm malignant
60+:
  • dyspnoea
  • mouth ulceration
  • swollen tongue
  • anaemia
  • bone marrow toxicity
  • pancytopenia
  • rectal haemorrhage
  • neutropenic sepsis
  • international normalised ratio increased
  • dysgeusia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Tramadol hydrochloride and Duspatal?

You may be interested in these reviews

More reviews for: Tramadol hydrochloride, Duspatal

On eHealthMe, Tramadol hydrochloride (tramadol hydrochloride) is often used to treat pain. Duspatal (mebeverine hydrochloride) is often used to treat crohn's disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.